Furthermore, the depletion of CRT from oral cancer cells resulted in the decreased activity of matrix metalloproteinase-2 (MMP-2) and MMP-9, possibly due to the downregulation of the FAK-ERK-MMP-2/MMP-9 signaling pathway (16). The gene discussed is MMP2; the disease is lip and oral cavity carcinoma.